Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001193125-26-234568

Director acquired 24,122 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stenhouse Mark Director 2026-05-19 Grant or award +24,122 54,122 D
Loading xslF345X06/ownership.xml…